Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T49493 | Target Info | |||
Target Name | Hemoglobin (HB) | ||||
Synonyms | Hemoglobin subunit alpha; Hemoglobin alpha chain; HBA1; Alpha-globin | ||||
Target Type | Successful Target | ||||
Gene Name | HBA2 | ||||
Biochemical Class | Pore-forming globin | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | Xenon | Ligand Info | |||
Canonical SMILES | [Xe] | ||||
InChI | 1S/Xe | ||||
InChIKey | FHNFHKCVQCLJFQ-UHFFFAOYSA-N | ||||
PubChem Compound ID | 23991 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 2W6V Structure of Human deoxy Hemoglobin A in complex with Xenon | ||||||
Method | X-ray diffraction | Resolution | 1.80 Å | Mutation | No | [1] |
PDB Sequence |
VLSPADKTNV
10 KAAWGKVGAH20 AGEYGAEALE30 RMFLSFPTTK40 TYFPHFDLSH50 GSAQVKGHGK 60 KVADALTNAV70 AHVDDMPNAL80 SALSDLHAHK90 LRVDPVNFKL100 LSHCLLVTLA 110 AHLPAEFTPA120 VHASLDKFLA130 SVSTVLTSKY140 R
|
|||||
|
||||||
PDB ID: 2W72 DEOXYGENATED STRUCTURE OF A DISTAL SITE HEMOGLOBIN MUTANT PLUS XE | ||||||
Method | X-ray diffraction | Resolution | 1.07 Å | Mutation | Yes | [1] |
PDB Sequence |
> Chain A
VLSPADKTNV 10 KAAWGKVGAH20 AGEYGAEAYE30 RMFLSFPTTK40 TYFPHFDLSH50 GSAQVKGQGK 60 KVADALTNAV70 AHVDDMPNAL80 SALSDLHAHK90 LRVDPVNFKL100 LSHCLLVTLA 110 AHLPAEFTPA120 VHASLDKFLA130 SVSTVLTSKY140 R> Chain B MHLTPEEKSA 10 VTALWGKVNV20 DEVGGEAYGR30 LLVVYPWTQR40 FFESFGDLST50 PDAVMGNPKV 60 KAQGKKVLGA70 FSDGLAHLDN80 LKGTFATLSE90 LHCDKLHVDP100 ENFRLLGNVL 110 VCVLAHHFGK120 EFTPPVQAAY130 QKVVAGVANA140 LAHKYH> Chain C MLSPADKTNV 10 KAAWGKVGAH20 AGEYGAEAYE30 RMFLSFPTTK40 TYFPHFDLSH50 GSAQVKGQGK 60 KVADALTNAV70 AHVDDMPNAL80 SALSDLHAHK90 LRVDPVNFKL100 LSHCLLVTLA 110 AHLPAEFTPA120 VHASLDKFLA130 SVSTVLTSKY140 R
|
|||||
|
VAL10[A]
4.593
ALA13[A]
3.540
TRP14[A]
2.186
ALA21[A]
3.515
TYR24[A]
4.111
GLY25[A]
3.793
ALA28[A]
3.973
TYR29[A]
4.231
PHE33[A]
4.348
PHE43[A]
3.420
PHE46[A]
2.393
LEU48[A]
3.917
GLN54[A]
3.776
VAL55[A]
3.669
GLN58[A]
3.880
VAL62[A]
3.393
ALA63[A]
4.231
LEU66[A]
4.330
VAL70[A]
4.333
LEU101[A]
3.805
SER102[A]
3.989
LEU105[A]
3.329
LEU109[A]
4.468
LEU113[A]
2.092
GLU116[A]
3.587
PHE117[A]
4.179
VAL121[A]
4.443
LEU125[A]
4.124
PHE128[A]
2.937
LEU129[A]
3.882
VAL23[B]
4.969
GLY24[B]
3.659
ALA27[B]
4.018
TYR28[B]
3.840
GLY64[B]
3.982
VAL67[B]
3.836
LEU68[B]
3.798
PHE71[B]
4.503
PHE103[B]
3.473
LEU106[B]
3.875
GLY107[B]
4.026
VAL134[B]
3.695
VAL137[B]
4.046
ALA138[B]
4.223
VAL10[C]
4.384
ALA13[C]
3.897
TRP14[C]
3.552
GLY25[C]
4.085
ALA28[C]
3.956
TYR29[C]
4.380
PHE33[C]
4.563
PHE43[C]
3.549
PHE46[C]
1.721
LEU48[C]
4.130
GLN54[C]
3.868
VAL55[C]
3.706
GLN58[C]
3.925
VAL62[C]
3.520
LEU66[C]
4.338
VAL70[C]
4.239
LEU101[C]
3.802
SER102[C]
4.129
LEU105[C]
3.977
LEU109[C]
4.187
LEU113[C]
4.157
GLU116[C]
3.769
PHE117[C]
4.213
VAL121[C]
4.529
LEU125[C]
4.193
PHE128[C]
3.399
LEU129[C]
3.846
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Pattern of cavities in globins: the case of human hemoglobin. Biopolymers. 2009 Dec;91(12):1097-107. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.